跳至主要内容
临床试验/NCT02190565
NCT02190565撤回不适用

Supplementation With WellnessPack Mama During Pregnancy and Lactation - a Randomized Double-blind, Placebo-controlled Study

Oriflame Cosmetics AB2 个研究点 分布在 1 个国家开始时间: 2018年4月7日最近更新:
适应症
干预措施

试验速览

阶段
不适用
状态
撤回
试验地点
2
主要终点
Prevalence of anaemia in active and placebo groups

研究概览

简要总结

The purpose of this study is to determine whether a food supplement consisting of vitamins, minerals and fish oil taken during and after pregnancy can decrease the need for additional iron supplementation due to anemia during pregnancy, and optimize levels of nutritional markers such as vitamin D and docosahexaenoic acid (DHA, an omega 3 fatty acid) in maternal blood and breast milk, compared to placebo.

详细描述

200 healthy, pregnant women will be randomized to receive either active or placebo at their first visit to the pre-natal centres. They will be monitored at regular intervals, blood samples will be taken and they will be asked about compliance and any adverse reactions.

Approx 8 weeks after delivery, the women will come to the pre-natal centres for a check-up. During this visit, a blood sample will be drawn and a breast milk sample will be collected.

The blood samples will be analysed for haemoglobin, serum ferritin, vitamin D and DHA. The breast milk samples will be analysed for vitamin D and DHA.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Prevention
盲法
Triple (Participant, Care Provider, Investigator)

入排标准

年龄范围
18 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • Healthy pregnant women aged 18-40 years with a body mass index (BMI) above 18.5 and below 35 kg/m2 who visit pre-natal clinics (midwife centres) to register.
  • Nulliparous and multiparous women.
  • The women must be able to understand verbal and written information in Swedish to give an informed consent to participate in the study.

排除标准

  • Women below the age of 18 or above 40 years old.
  • Women with a BMI below 18.5 or above 35 kg/m
  • Women with any form of anaemia as diagnosed at the first visit to the prenatal clinic.
  • Women expecting two or more babies.
  • Women who have undergone bariatric surgery.
  • Women on medication with pharmaceuticals that could affect the result of the study, e.g., vitamin K antagonists.
  • Women who are allergic to any of the components of WellnessPack mama, e.g., fish.
  • Women who suffer from drug or alcohol abuse.
  • Women who suffer from known severe eating disorders.
  • Women who suffer from chronic diseases that could affect gastrointestinal absorption and metabolism.
  • Women who want to continue or start using similar food supplements in addition to WellnessPack mama/placebo, unless recommended by a physician or midwife, will be excluded from the study.
  • Upon miscarriage or transfer to prenatal care specialist, the subject is excluded from the study.

研究组 & 干预措施

Placebo

Placebo Comparator

Placebo consisting of two sham multivitamin and mineral tablets and two capsules of oil

干预措施: Food supplement (Dietary Supplement)

Food supplement

Active Comparator

Food supplement consisting of fish oil (omega 3 fatty acids DHA and EPA) and multivitamin and mineral tablets with extra iron and folic acid

干预措施: Food supplement (Dietary Supplement)

结局指标

主要结局

Prevalence of anaemia in active and placebo groups

时间窗: pregnancy week 28-30

Blood will be analysed for haemoglobin and ferritin values. We will compare how many women in each group (active vs placebo) are ordinated iron supplementation due to anaemia by mid-pregnancy.

次要结局

  • Levels of nutritional biomarkers in maternal blood and breast milk(6-10 weeks after delivery)

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验